omega-n-methylarginine has been researched along with eye in 6 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (eye) | Trials (eye) | Recent Studies (post-2010) (eye) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 41,716 | 724 | 8,737 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, H; Breiteneder, H; Eichler, HG; Fasching, P; Ferber, W; Findl, O; Schmetterer, L; Strenn, K; Wolzt, M | 1 |
| Eichler, HG; Findl, O; Graselli, U; Kastner, J; Schmetterer, L; Strenn, K; Wolzt, M | 1 |
| Brock, TA; Chang, KC; LeJeune, WS; Stephan, CC; Tilton, RG; Williamson, JR | 1 |
| Dallinger, S; Eichler, HG; Findl, O; Kiss, B; Rainer, G; Schmetterer, L | 1 |
| Bayerle-Eder, M; Dorner, GT; Fasching, P; Garhöfer, G; Schmetterer, L; Selenko, N; Wolzt, M | 1 |
| Dorner, GT; Garhöfer, G; Golestani, E; Huemer, KH; Schmetterer, L; Wolzt, M; Zawinka, C | 1 |
3 trial(s) available for omega-n-methylarginine and eye
| Article | Year |
|---|---|
Nitric oxide and ocular blood flow in patients with IDDM.
Topics: Adult; Arginine; Blood Flow Velocity; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Enzyme Inhibitors; Eye; Hemodynamics; Humans; Infusions, Intravenous; Lasers; Male; Microscopy, Interference; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Ophthalmic Artery; Pulsatile Flow; Time Factors | 1997 |
Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide.
Topics: Acetazolamide; Adult; Arginine; Blood Vessels; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Eye; Humans; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1999 |
Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery.
Topics: Adrenomedullin; Adult; Blood Flow Velocity; Blood Pressure; Choroid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Eye; Hemodynamics; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Nitric Oxide; omega-N-Methylarginine; Ophthalmic Artery; Peptides; Pilot Projects; Vasodilator Agents | 2003 |
3 other study(ies) available for omega-n-methylarginine and eye
| Article | Year |
|---|---|
Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebral Arteries; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Eye; Hemodynamics; Humans; Hyperoxia; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Ophthalmic Artery; Oxygen; Partial Pressure; Pulse; Random Allocation; Time Factors | 1997 |
Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Topics: Animals; Capillary Permeability; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Eye; Hemodynamics; Infusions, Intravenous; Lymphokines; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serum Albumin, Bovine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eye; Hemodynamics; Humans; Injections, Intravenous; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Ophthalmic Artery; Pulse; Single-Blind Method; Time Factors | 2003 |